Last $8.48 USD
Change Today +0.12 / 1.44%
Volume 27.3K
CCM On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 8:04 PM 07/22/14 All times are local (Market data is delayed by at least 15 minutes).

concord medical - spon adr (CCM) Snapshot

Open
$8.38
Previous Close
$8.36
Day High
$8.54
Day Low
$8.36
52 Week High
03/5/14 - $10.08
52 Week Low
09/9/13 - $3.57
Market Cap
381.1M
Average Volume 10 Days
37.7K
EPS TTM
$0.35
Shares Outstanding
44.9M
EX-Date
01/16/14
P/E TM
24.1x
Dividend
--
Dividend Yield
8.49%
Current Stock Chart for CONCORD MEDICAL - SPON ADR (CCM)

concord medical - spon adr (CCM) Related Bloomberg News

View More Bloomberg News

concord medical - spon adr (CCM) Related Businessweek News

View More BusinessWeek News

concord medical - spon adr (CCM) Details

Concord Medical Services Holdings Limited, through its subsidiaries, operates radiotherapy and diagnostic imaging centers. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy, and diagnostic imaging services. The company also offers other treatments and diagnostic services through the use of medical equipment comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson’s disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. In addition, it provides clinical support services, such as developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, the company offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as is engaged in the sale of medical equipment. The company, through its subsidiaries, holds 52% equity interest in Chang’an Hospital, a non-public general hospital with 1,100 hospital beds located in Xi’an, Shaanxi Province. It also focuses on establishing the Beijing Proton Medical Center that would offer radiotherapy treatment options to cancer patients; and Guangzhou Concord Medical Cancer Hospital, a 400-bed specialty hospital for cancer diagnosis and treatment, as well as other specialty cancer hospitals that would offer radiotherapy services, diagnostic imaging services, chemotherapy, and surgery. As of December 31, 2013, its network comprised 144 centers based in 81 hospitals, spanning 55 cities across 25 provinces and administrative regions in China. The company was founded in 1996 and is headquartered in Beijing, the People’s Republic of China.

608 Employees
Last Reported Date: 04/28/14
Founded in 1996

concord medical - spon adr (CCM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

concord medical - spon adr (CCM) Key Developments

Concord Medical Services Holdings Limited Announces Executive Changes

Concord Medical Services Holdings Limited announced the new appointments to the management team. The board has appointed Mr. Yaw Kong Yap as the new chief financial officer, effective July 1, 2014 and Mr. Adam Jigang Sun as the chief investment officer, effective July 1, 2014. Mr. Sun will no longer serve as the chief financial officer of the company. In his new position, Mr. Sun will be leading the review and approval of external investment projects while continuing to lead the Company’s investor relations program. Mr. Yaw Kong Yap has served as a senior vice president for the Company since 2011. He served as a member of the board of directors and financial controller for the Company from 2008 to 2011. Mr. Yap joined China Medstar in 2005 and served as its chief financial officer prior its acquisition by the Company. Prior to joining China Medstar, Mr. Yap served as the chief executive officer of Advanced Produce Centre Development Pte Ltd. from 2003 to 2005, the chief financial officer of Global Fruits Pte Limited from 1999 to 2003, the regional financial controller of America Air Filtration Asia from 1996 to 1998, and the financial controller of Chevalier International (USA) Ltd. from 1991 to 1996.

Concord Medical Services Holdings Limited Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Full Year of 2014

Concord Medical Services Holdings Limited announced unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported total net revenues of RMB 252,635,000 compared with RMB 203,914,000 for the same period a year ago. Operating income was RMB 38,448,000 compared with RMB 29,613,000 for the same period a year ago. Income before income taxes was RMB 39,984,000 compared with RMB 29,852,000 for the same period a year ago. Net income attributable to ordinary shareholders was RMB 26,657,000 or RMB 0.58 per basic and diluted share compared with RMB 19,683,000 or RMB 0.44 per basic and diluted share for the same period a year ago. Non GAAP operating income was RMB 40,293,000 compared with RMB 31,857,000 for the same period a year ago. Non GAAP net income was RMB 28,907,000 or RMB 0.62 per basic and diluted ADS compared with RMB 21,284,000 or RMB 0.49 per basic and diluted ADS for the same period a year ago. Adjusted EBITDA was RMB 97,058,000 compared with RMB 83,568,000 for the same period a year ago. Capital expenditure of the hospital business was RMB 7.8 million ($1.3 million) for the first quarter of 2014, compared with RMB 9.8 million for the first quarter of 2013. Capital expenditure of the network business was RMB 7.1 million ($1.1 million) for the first quarter of 2014, compared with RMB 33.8 million in the first quarter of 2013. For the fiscal year of 2014, the company expects earnings in the range of $0.45 to $0.50 per ADS, or $20.3 million to $22.5 million in net income attributable to ordinary shareholders.

Concord Medical Services Holdings Limited to Report Q1, 2014 Results on May 21, 2014

Concord Medical Services Holdings Limited announced that they will report Q1, 2014 results at 6:00 PM, Eastern Daylight on May 21, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCM:US $8.48 USD +0.12

CCM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Renji Medical Group Ltd/Hong Kong $0.45 HKD -0.01
View Industry Companies
 

Industry Analysis

CCM

Industry Average

Valuation CCM Industry Range
Price/Earnings 25.4x
Price/Sales 2.3x
Price/Book 1.2x
Price/Cash Flow 9.3x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONCORD MEDICAL - SPON ADR, please visit www.cmsholdings.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.